Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Often, at first, patients report extreme nausea and constipation, which both contribute to a lack of appetite
The lack of regulation and limited clinical research further complicate the picture, leaving much about its safety uncertain
The absence of reported harm does not equal evidence of safety in pregnancy, which is why medical societies consistently recommend discontinuation before conception
Tirzepatide drugs were removed from the FDA Drug Shortage Database as of October 2, 2024
US$ 23.51
US$ 20.25
US$ 22.66
US$ 23.22
US$ 26.23
US$ 27.82
US$ 26.46
US$ 27.28
US$ 28.08
US$ 22.19
US$ 24.87
